Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1993 Jul;9(1):51-9.
doi: 10.2165/00002018-199309010-00005.

Epidemiology of drug-drug interactions as a cause of hospital admissions

Affiliations
Review

Epidemiology of drug-drug interactions as a cause of hospital admissions

C A Jankel et al. Drug Saf. 1993 Jul.

Abstract

The purpose of this review was to focus on hospital admissions caused by a specific type of adverse drug reaction (ADR) that can be assumed to be avoidable in almost all cases: the drug-drug interaction (D-DI). To determine the epidemiology of D-DIs in hospital admissions, a review of the adverse drug reaction literature was undertaken to answer several questions: (a) what is the incidence of hospital admissions attributable to D-DIs?; (b) what percentage of drug-related hospital admissions are attributable to D-DIs?; (c) are there any patterns to the above findings, i.e. are some D-DIs or specific drugs more likely to have been associated with hospital admissions?; and (d) are there certain patient risk factors (e.g. age) that are associated with D-DIs that led to a hospital admission? Nine ADR studies were found that either included a D-DI category as a cause for hospital admissions, or provided sufficient information so that a causal relationship could be inferred. The incidence of hospital admissions due to D-DIs ranged from 0 to 2.8%. The data found in the studies we reviewed, however, were insufficient to allow meaningful quantification of specific drugs as usual causes for D-DI-related admissions, and because of the very small numbers of patients for which a D-DI was believed to be the cause it is not possible to provide a meaningful summary of risk factors specific for D-DI admissions. We cannot conclude that D-DIs are a significant problem. There is a need to view the quantification of D-DIs in relation to the number of medications prescribed by physicians, dispensed by pharmacists and taken by patients.

PubMed Disclaimer

References

    1. Can Med Assoc J. 1967 Dec 9;97(24):1450-7 - PubMed
    1. Am J Hosp Pharm. 1977 Jul;34(7):738-42 - PubMed
    1. Drug Saf. 1991 Nov-Dec;6(6):450-9 - PubMed
    1. Br J Clin Pharmacol. 1992 Jan;33(1):61-8 - PubMed
    1. Br Med J. 1969 Mar 1;1(5643):536-9 - PubMed